Holzhauer, Laura et al. published their research in Beilstein Journal of Organic Chemistry in 2022 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Quality Control of Quinoxalin-2-amine

Scope of tetrazolo[1,5-a]quinoxalines in CuAAC reactions for the synthesis of triazoloquinoxalines, imidazoloquinoxalines, and rhenium complexes thereof was written by Holzhauer, Laura;Liagre, Chloe;Fuhr, Olaf;Jung, Nicole;Braese, Stefan. And the article was included in Beilstein Journal of Organic Chemistry in 2022.Quality Control of Quinoxalin-2-amine This article mentions the following:

The conversion of tetrazolo[1,5-a]quinoxalines I (R = H, i-Pr, Ph, etc.) to 1,2,3-triazoloquinoxalines II (R1 = n-Bu, Ph, 1,3-dioxo-isoindolinylmethyl, etc.) and triazoloimidazoquinoxalines III (R1 = Ph, n-Bu)under typical conditions of a CuAAC reaction has been investigated. Derivatives of the novel compound class of triazoloimidazoquinoxalines (TIQ) and rhenium(I) triazoloquinoxaline complexes IV and [N,N-diethyl-2-(1-(quinoxalin-2-yl)-1H-1,2,3-triazol-4-yl)ethan-1-amine]bromotricarbonylrhenium(I) as well as a new TIQ rhenium complex such as [1-butyl-4-(4-butyl-1H-1,2,3-triazol-1-yl)imidazo[1,2-a]quinoxaline]bromotricarbonylrhenium(I) were synthesized. As a result, a small 1,2,3-triazoloquinoxaline library was obtained and the method could be expanded towards 4-substituted tetrazoloquinoxalines. The compatibility of various aliphatic and aromatic alkynes R1CCH towards the reaction was investigated and the denitrogenative annulation towards imidazoloquinoxalines V could be observed as a competing reaction depending on the alkyne concentration and the substitutions at the quinoxaline. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Quality Control of Quinoxalin-2-amine).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Quality Control of Quinoxalin-2-amine

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Weijlard, John et al. published their research in Journal of the American Chemical Society in 1944 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Product Details of 5424-05-5

Sulfaquinoxaline and some related compounds was written by Weijlard, John;Tishler, Max;Erickson, A. E.. And the article was included in Journal of the American Chemical Society in 1944.Product Details of 5424-05-5 This article mentions the following:

Alloxazine (I) (10 g.) and 50 cc. concentrated NH4OH, heated in a steel bomb at 170-5° for 5 h., give 71.3% of 2-amino-3-quinoxalinecarboxylic acid (II), m. 204°. II (2 g.) in 8 cc. PhNO2, refluxed 10 min., give 92% of 2-aminoquinoxaline (III), m. 155-6°; I (2 g.) and 10 cc. 95% H2SO4, heated at 240-5° for 10 min., give 56% of III. Ac derivative of III, yellow, m. 192.5-3.5°. II (10 g.) and alc. HCl, refluxed 3 h., give 8.5 g. of the Et ester (IV), m. 165-6° (HCl salt, m. 173-5°). From 0.69 g. III in 200 cc. reagent C5H5N at -5° treated (after 2 min.) with 1.23 g. AcNHC6H4SO2Cl (V), with alternate additions of III and V at 5-min. intervals until 20.7 g. of III and 36.9 g. of V had been added at 0°, stirred 1 h. at 0° and 4 h. at room temperature, concentrated to dryness and washed with H2O at 0°, there resulted 91.2% of 2-N4-acetylsulfanilamidoquinoxaline, m. 243-4°; refluxing 6 g. with 25 cc. concentrated HCl and 50 cc. EtOH for 1 h. gives 3.85 g. of 2-sulfanilamidoquinoxaline (VI), m. 247-8°; N4-Bz derivative, m. 259-60°; N4-caproyl derivative, m. 199-200°; β-carboxypropionyl derivative, m. 234-5°. 2-N4-Acetylsulfanilamido-3-carbethoxyquinoxaline, m. 236-7°. Condensation of IV and V, followed by hydrolysis, gives 2-sulfanilamido-3-carboxyquinoxaline, m. 238-9°. II could not be condensed with V. Preliminary chemotherapeutic studies indicate that VII is very effective in bacterial infections and that it has the unusual property of being eliminated by animals very slowly so that effective concentrations can be maintained by administering it at comparatively infrequent intervals. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Product Details of 5424-05-5).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Product Details of 5424-05-5

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Nassar, Rania et al. published their research in Environmental Science and Pollution Research in 2018 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Reference of 5424-05-5

Transformation of sulfaquinoxaline by chlorine and UV light in water: kinetics and by-product identification was written by Nassar, Rania;Mokh, Samia;Rifai, Ahmad;Chamas, Fatmeh;Hoteit, Maha;Al Iskandarani, Mohamad. And the article was included in Environmental Science and Pollution Research in 2018.Reference of 5424-05-5 This article mentions the following:

Sulfaquinoxaline (SQX) is an antimicrobial of the sulfonamide class, frequently detected at low levels in drinking and surface water as organic micropollutant. The main goal of the present study is the evaluation of SQX reactivity during chlorination and UV irradiations which are two processes mainly used in water treatment plants. The SQX transformation by chlorination and UV lights (254 nm) was investigated in purified water at common conditions used for water disinfection (pH = 7.2, temperature = 25°C, [chlorine] = 3 mg L-1). The result shows a slow degradation of SQX during photolysis compared with chlorination process. Kinetic studies that fitted a fluence-based first-order kinetic model were used to determine the kinetic constants of SQX degradation; they were equal to 0.7 × 10-4 and 0.7 × 10-2 s-1corresponding to the half time lives of 162 and 1.64 min during photolysis and chlorination, resp. In the second step, seven byproducts were generated during a chlorination and photo-transformation of SQX and identified using liquid chromatog. with electrospray ionization and tandem mass spectrometry (MS-MS). SO2 extrusion and direct decomposition were the common degradation pathway during photolysis and chlorination. Hydroxylation and isomerization were observed during photodegradation only while electrophilic substitution was observed during chlorination process. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Reference of 5424-05-5).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Reference of 5424-05-5

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Willems, Sabine et al. published their research in ChemMedChem in 2022 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Quinoxaline and its analogues may also be formed by reduction of amino acids substituted 1,5-difluoro-2,4-dinitrobenzene (DFDNB),One study used 2-iodoxybenzoic acid (IBX) as a catalyst in the reaction of benzil with 1,2-diaminobenzene.Safety of Quinoxalin-2-amine

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries was written by Willems, Sabine;Mueller, Marcel;Ohrndorf, Julia;Heering, Jan;Proschak, Ewgenij;Merk, Daniel. And the article was included in ChemMedChem in 2022.Safety of Quinoxalin-2-amine This article mentions the following:

Several lines of evidence suggest the ligand-sensing transcription factor Nurr1 as a promising target to treat neurodegenerative diseases. Nurr1 modulators to validate and exploit this therapeutic potential are rare, however. To identify novel Nurr1 agonist chemotypes, we have employed the Nurr1 activator amodiaquine as template for microscale analog library synthesis. The first set of analogs was based on the 7-chloroquiolin-4-amine core fragment of amodiaquine and revealed superior N-substituents compared to diethylaminomethylphenol contained in the template. A second library of analogs was subsequently prepared to replace the chloroquinolineamine scaffold. The two sets of analogs enabled a full scaffold hop from amodiaquine to a novel Nurr1 agonist sharing no structural features with the lead but comprising superior potency on Nurr1. Addnl., pharmacophore modeling based on the entire set of active and inactive analogs suggested key features for Nurr1 agonists. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Safety of Quinoxalin-2-amine).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Quinoxaline and its analogues may also be formed by reduction of amino acids substituted 1,5-difluoro-2,4-dinitrobenzene (DFDNB),One study used 2-iodoxybenzoic acid (IBX) as a catalyst in the reaction of benzil with 1,2-diaminobenzene.Safety of Quinoxalin-2-amine

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Iijima, Chihoko et al. published their research in Yakugaku Zasshi in 1989 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Quality Control of Quinoxalin-2-amine

Quinoxalines. XXV. Synthesis and chemical properties of 2-nitroquinoxaline was written by Iijima, Chihoko. And the article was included in Yakugaku Zasshi in 1989.Quality Control of Quinoxalin-2-amine This article mentions the following:

2-Nitroquinoxaline (I) was synthesized and the chem. properties were investigated. The reaction of 2-iodoquinoxaline with AgNO2 in the presence of Bu4NF gave 44% I. I is quite reactive toward various nucleophiles and the ipso-substitution reaction of I with O-nucleophiles (OH, CH3O, C2H5O, C8H5O), S-nucleophiles (CH3S, C6H5S, p-CH3C6H5SO2), N-nucleophiles (hexylamine, cyclohexylamine, piperidine, morpholine, aniline), and C-nucleophiles (CN, di-Et malonate, malonodinitrile, benzyl cyanide, Et cyanoacetate, nitroethane, acetophenone) readily afforded the corresponding 2-substituted quinoxalines. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Quality Control of Quinoxalin-2-amine).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Quality Control of Quinoxalin-2-amine

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Iijima, Chihoko et al. published their research in Yakugaku Zasshi in 1988 | CAS: 5424-05-5

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson’s, and Alzheimer’s diseases. Quinoxalines are used in the treatment of bacterial, cancer, and HIV infections. Moreover, varenicline, a clinical drug is used for treating nicotine addiction, also contains quinoxaline moiety.Category: quinoxaline

Quinoxalines. XXIII. Reaction of 2-chloroquinoxaline with nucleophiles was written by Iijima, Chihoko;Hayashi, Eisaku. And the article was included in Yakugaku Zasshi in 1988.Category: quinoxaline This article mentions the following:

2-Chloroquinoxaline (I, R = Cl) reacted with NaI, NaSO2C6H4R1-4 (R1 = H, Me), or KSCN to afford quinoxaline derivatives I (R = I, SO2C6H4R1-4, SCN; R1 = H, Me) in good yields. Cyano and nitro groups were introduced into the 2-position of quinoxaline in low yield by using KCN and AgNO. In the experiment, the researchers used many compounds, for example, Quinoxalin-2-amine (cas: 5424-05-5Category: quinoxaline).

Quinoxalin-2-amine (cas: 5424-05-5) belongs to quinoxaline derivatives. Quinoxalines have received a significant amount of attention due to their potential use in fighting various pathophysiological conditions like epilepsy, Parkinson’s, and Alzheimer’s diseases. Quinoxalines are used in the treatment of bacterial, cancer, and HIV infections. Moreover, varenicline, a clinical drug is used for treating nicotine addiction, also contains quinoxaline moiety.Category: quinoxaline

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider